Showing results 1 to 20 of 28
next >
| Issue Date | Title | Author(s) |
| 2015 | 4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass | Chang, Lung-Ji; Dong, Lujia; Zhu, Jun; Ying, Zhitao; Kuo, Hao-Hsian; Liu, Yuchen; Song, Yu-Qin; Wang, Xiao-Pei; Jia, Yong-Qian; Niu, Ting; Liu, Ting; Pan, Ling; Liu, Zhuo-Gang; Li, Tong; Li, Ying-Chun; Yao, Kun; Ke, Xiaoyan; Jing, Hongmei; Bao, Fang |
| 2015 | 4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass | Chang, Lung-Ji; Dong, Lujia; Zhu, Jun; Ying, Zhitao; Kuo, Hao-Hsian; Liu, Yuchen; Song, Yu-Qin; Wang, Xiao-Pei; Jia, Yong-Qian; Niu, Ting; Liu, Ting; Pan, Ling; Liu, Zhuo-Gang; Li, Tong; Li, Ying-Chun; Yao, Kun; Ke, Xiaoyan; Jing, Hongmei; Bao, Fang |
| 2018 | CD19 CAR T Cell Product Exhibits High Remission Rate in Adult Relapsed and/or Refractory B-Cell Non-Hodgkin Lymphoma | Ying, Zhitao; Wang, Wen; Wang, Xiaopei; Zheng, Wen; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Ping, Lingyan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Hao, Ming; Yang, Su; Zhou, Yan; Li, James; Song, Yuqin; Zhu, Jun |
| 2017 | Chimeric antigen receptor-modified T cells directed against CD19 in patients with relapsed or refractory CD19-positive B-cell lymphomas: interim analysis of a phase 1 study | Ying, Zhitao; Xiang, Xiaoyu; Song, Yuqin; Ding, Ning; Lin, Yufu; Zheng, Wen; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Liu, Yanling; Yue, Yunqiang; Yu, Xueyun; Liu, Hanzhi; Duan, Panpan; Mamuti, Mierzhati; Guo, Xiaokai; Chen, Feng; Wu, Xiaoyan; Zhang, Junqing; Zhang, Tingting; Huang, Xue F.; Jones, Lindsey; Kang, Xi; Chen, Si-Yi; Zhu, Jun |
| 2016 | Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome | Jia, Jing; Song, Yuqin; Lin, Ningjing; Liu, Weiping; Ping, Lingyan; Zheng, Wen; Wang, Xiaopei; Xie, Yan; Tu, Meifeng; Zhang, Chen; Ying, Zhitao; Deng, Lijuan; Ding, Ning; Zhu, Jun |
| 2019 | Clinical presentation determines selection of patients for initial observation in mantle cell lymphoma | Kumar, Anita; Ying, Zhitao; Alperovich, Anna; Dogan, Ahmet; Hamlin, Paul; Moskowitz, Craig; Pichardo, Janine; Portlock, Carol; Sha, Fushen; Zelenetz, Andrew D.; Zhang, Zhigang; Drill, Esther; Woo, Kaitlin; Younes, Anas |
| 2019 | Combination of Enzastaurin and Ibrutinib synergistically induces anti-tumor effects in diffuse large B cell lymphoma | He, Yizi; Li, Jiao; Ding, Ning; Wang, Xiaogan; Deng, Lijuan; Xie, Yan; Ying, Zhitao; Liu, Weiping; Ping, Lingyan; Zhang, Chen; Song, Yuqin; Zhu, Jun |
| 25-Feb-2021 | Distribution of chimeric antigen receptor-modified T cells against CD19 in B-cell malignancies | Ying, Zhitao; He, Ting; Wang, Xiaopei; Zheng, Wen; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Ping, Lingyan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Wu, Meng; Feng, Feier; Leng, Xin; Du, Tingting; Qi, Feifei; Hu, Xuelian; Ding, Yanping; Lu, Xin-an; Song, Yuqin; Zhu, Jun |
| 15-Nov-2022 | Efficacy and Safety of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma in China | Song, Yuqin; Ying, Zhitao; Yang, Haiyan; Guo, Ye; Li, Wenyu; Zou, Dehui; Wu, Jianqiu; Tian, Alex; Huang, Tony; Zhou, Zisong; Ma, Meilin; Yang, Su; Qin, Yun; Zhu, Jun |
| Dec-2022 | Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trial | Ying, Zhitao; Xie, Yan; Zheng, Wen; Liu, Weiping; Lin, Ningjing; Tu, Meifeng; Wang, Xiaopei; Ping, Lingyan; Deng, Lijuan; Zhang, Chen; Wu, Meng; Feng, Feier; Du, Tingting; Tang, Yongjing; Su, Fang; Guo, Ziyu; Li, James; Song, Yuqin; Zhu, Jun |
| 2017 | EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP | Li, Jiao; Ding, Ning; Wang, Xiaogan; Mi, Lan; Ping, Lingyan; Jin, Xuan; Liu, Yalu; Ying, Zhitao; Xie, Yan; Liu, Weiping; Song, Yuqin; Zhu, Jun |
| 2018 | ET190L1-Artemis (TM) Cell Therapy Results in Durable Disease Remissions with No Cytokine Release Syndrome or Neurotoxicity in Patients with Relapsed and Refractory B-Cell Lymphoma | Ying, Zhitao; Long, Li; Liu, Hong; Song, Yuqin; Rizzieri, David A.; Nejadnik, Bijan; Zhu, Jun; Liu, Cheng |
| 2017 | Evaluating early interim fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography with the SUVmax-liver-based interpretation for predicting the outcome in diffuse large B-cell lymphoma | Fan, Yang; Zhang, Yuewei; Yang, Zhi; Ying, Zhitao; Zhou, Nina; Liu, Chen; Song, Yuqin; Zhu, Jun; Wang, Xuejuan |
| 2015 | Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin | Deng, Lijuan; Song, Yuqin; Young, Ken H.; Hu, Shimin; Ding, Ning; Song, Weiwei; Li, Xianghong; Shi, Yunfei; Huang, Huiying; Liu, Weiping; Zheng, Wen; Wang, Xiaopei; Xie, Yan; Lin, Ningjing; Tu, Meifeng; Ping, Lingyan; Ying, Zhitao; Zhang, Chen; Sun, Yingli; Zhu, Jun |
| 2019 | ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma | Liu, Yalu; Wang, Xiaogan; Deng, Lijuan; Ping, Lingyan; Shi, Yunfei; Zheng, Wen; Lin, Ningjing; Wang, Xiaopei; Tu, Meifeng; Xie, Yan; Liu, Weiping; Ying, Zhitao; Zhang, Chen; Pan, Zhengying; Wang, Xi; Ding, Ning; Song, Yuqin; Zhu, Jun |
| 2018 | The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma | Li, Jiao; Wang, Xiaogan; Xie, Yan; Ying, Zhitao; Liu, Weiping; Ping, Lingyan; Zhang, Chen; Pan, Zhengying; Ding, Ning; Song, Yuqin; Zhu, Jun |
| 2015 | Outcomes of dose-adjusted Berlin-Frankfurt-Munster-90 regimen without radiotherapy in adolescents and adults with T cell lymphoblastic lymphoma | Xie, Yan; Zhang, Yuntao; Zheng, Wen; Wang, Xiaopei; Lin, Ningjing; Tu, Meifeng; Ping, Lingyan; Ying, Zhitao; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Song, Yuqin; Zhu, Jun |
| 2018 | PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity | Zheng, Wen; Gao, Yuhuan; Ke, Xiaoyan; Zhang, Weijing; Su, Liping; Ren, Hanyun; Lin, Ningjing; Xie, Yan; Tu, Meifeng; Liu, Weiping; Ping, Lingyan; Ying, Zhitao; Zhang, Chen; Deng, Lijuan; Wang, Xiaopei; Song, Yuqin; Zhu, Jun |
| Feb-2020 | Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma | Batlevi, Connie L.; Sha, Fushen; Alperovich, Anna; Ni, Ai; Smith, Katy; Ying, Zhitao; Getreciano, John F.; Hamlin, Paul A.; Horwitz, Steve M.; Joffe, Erel; Kumar, Anita; Matasar, Matthew J.; Moskowitz, Alison J.; Moskowitz, Craig H.; Noy, Ariela; Owens, Colette; Palomba, Lia M.; Straus, David; von Keudell, Gottfried; Zelenetz, Andrew D.; Seshan, Venkatraman E.; Luminari, Stefano; Marcheselli, Luigi; Federico, Massimo; Younes, Anas |
| 2019 | Prognostic value of F-18-fluorodeoxyglucose positron emission tomography using Deauville criteria in diffuse large B cell lymphoma treated with autologous hematopoietic stem cell transplantation | Ying, Zhitao; Mi, Lan; Zhou, Nina; Wang, Xuejuan; Yang, Zhi; Song, Yuqin; Wang, Xiaopei; Zheng, Wen; Lin, Ningjing; Tu, Meifeng; Xie, Yan; Ping, Lingyan; Zhang, Chen; Liu, Weiping; Deng, Lijuan; Zhu, Jun |
